Quarterly Report

Amneal Pharmaceuticals, Inc. Filed 2020-05-11 Acc 0001564590-20-024256

Documents 1

2020-08-06 10-Q Quarterly Report
2020-05-11 10-Q Quarterly Report
2020-05-11 8-K Results of operations · Regulation FD disclosure
2020-05-08 4 Exec VP, Comm Optns gave up 8,353 shares (to pay taxes)
2020-05-08 4 SVP, Specialty Commercial gave up 2,212 shares (to pay taxes)
2020-05-08 4 President, Co-CEO & Director acquired 6,459 shares (option exercise)
2019-11-07 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading amrx-10q_20200331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…